Prostate cancer cell proliferation, migration and invasion were reversed in the SFT2D2‐TBX19 overexpression group following ATP5F1A or ATP5F1B knockdown (Figure 7I–L and Figure S9B–E, Supporting Information). The gene discussed is ATP5F1A; the disease is prostate carcinoma.